Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913071400> ?p ?o ?g. }
- W2913071400 endingPage "617" @default.
- W2913071400 startingPage "613" @default.
- W2913071400 abstract "Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and is becoming the most frequent indication of liver transplantation. Cardiovascular disease is the main cause of death in these patients. There is no Food and Drug Association-approved medication for NAFLD patients. We aimed to provide more robust evidence on the use of medications that are inexpensive and available, namely, metformin, silymarin, pioglitazone, and vitamin E, for treating NAFLD.We conducted a randomized double-blinded, placebo-controlled trial on 150 consecutive patients with NAFLD who were assigned to five groups: lifestyle plus placebo, metformin 500 mg/day, silymarin 140 mg/day, pioglithasone 15 mg/day, and vitamin E 400 IU/day, all for 3 months. Anthropometric and biochemical variables were measured at baseline and 3 months later.The mean age of the patients was 47.0±9.1 (range: 18-65) years and the sex distribution was 73 (48.7%) women and 77 (51.3%) men. Patients in all groups showed a significant improvement in anthropometric parameters such as waist circumference and BMI. There was no statistically significant difference in alanine transaminase and aspartate transaminase in the control group after treatment (P=0.51, 0.18, respectively); however, both liver enzymes decreased significantly in the other groups.This randomized double-blinded placebo-controlled clinical trial suggested a significant benefit of silymarin, pioglitazone, and vitamin E in improving liver aminotransferases in patients with NAFLD after only 3 months, without exerting any specific side effects." @default.
- W2913071400 created "2019-02-21" @default.
- W2913071400 creator A5018728704 @default.
- W2913071400 creator A5024561441 @default.
- W2913071400 creator A5028196908 @default.
- W2913071400 creator A5031179258 @default.
- W2913071400 date "2019-05-01" @default.
- W2913071400 modified "2023-09-29" @default.
- W2913071400 title "Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial" @default.
- W2913071400 cites W1868475579 @default.
- W2913071400 cites W1908780918 @default.
- W2913071400 cites W1963683487 @default.
- W2913071400 cites W1968396962 @default.
- W2913071400 cites W1977188464 @default.
- W2913071400 cites W1978128204 @default.
- W2913071400 cites W1981419458 @default.
- W2913071400 cites W1998383277 @default.
- W2913071400 cites W2046859247 @default.
- W2913071400 cites W2074503081 @default.
- W2913071400 cites W2075272295 @default.
- W2913071400 cites W2091106363 @default.
- W2913071400 cites W2153068313 @default.
- W2913071400 cites W2161883681 @default.
- W2913071400 cites W2162382402 @default.
- W2913071400 cites W2380501139 @default.
- W2913071400 cites W2470709274 @default.
- W2913071400 cites W2580291574 @default.
- W2913071400 cites W2607263910 @default.
- W2913071400 cites W2610447557 @default.
- W2913071400 cites W2758990245 @default.
- W2913071400 cites W2775135060 @default.
- W2913071400 cites W2901881991 @default.
- W2913071400 doi "https://doi.org/10.1097/meg.0000000000001369" @default.
- W2913071400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30920975" @default.
- W2913071400 hasPublicationYear "2019" @default.
- W2913071400 type Work @default.
- W2913071400 sameAs 2913071400 @default.
- W2913071400 citedByCount "46" @default.
- W2913071400 countsByYear W29130714002019 @default.
- W2913071400 countsByYear W29130714002020 @default.
- W2913071400 countsByYear W29130714002021 @default.
- W2913071400 countsByYear W29130714002022 @default.
- W2913071400 countsByYear W29130714002023 @default.
- W2913071400 crossrefType "journal-article" @default.
- W2913071400 hasAuthorship W2913071400A5018728704 @default.
- W2913071400 hasAuthorship W2913071400A5024561441 @default.
- W2913071400 hasAuthorship W2913071400A5028196908 @default.
- W2913071400 hasAuthorship W2913071400A5031179258 @default.
- W2913071400 hasConcept C126322002 @default.
- W2913071400 hasConcept C134018914 @default.
- W2913071400 hasConcept C141071460 @default.
- W2913071400 hasConcept C142724271 @default.
- W2913071400 hasConcept C160160445 @default.
- W2913071400 hasConcept C168563851 @default.
- W2913071400 hasConcept C181199279 @default.
- W2913071400 hasConcept C185592680 @default.
- W2913071400 hasConcept C204787440 @default.
- W2913071400 hasConcept C27081682 @default.
- W2913071400 hasConcept C2776954865 @default.
- W2913071400 hasConcept C2777075537 @default.
- W2913071400 hasConcept C2777180221 @default.
- W2913071400 hasConcept C2778384471 @default.
- W2913071400 hasConcept C2778606649 @default.
- W2913071400 hasConcept C2778772119 @default.
- W2913071400 hasConcept C2779134260 @default.
- W2913071400 hasConcept C2779306644 @default.
- W2913071400 hasConcept C2779679107 @default.
- W2913071400 hasConcept C2780323712 @default.
- W2913071400 hasConcept C55493867 @default.
- W2913071400 hasConcept C555293320 @default.
- W2913071400 hasConcept C71924100 @default.
- W2913071400 hasConcept C90924648 @default.
- W2913071400 hasConceptScore W2913071400C126322002 @default.
- W2913071400 hasConceptScore W2913071400C134018914 @default.
- W2913071400 hasConceptScore W2913071400C141071460 @default.
- W2913071400 hasConceptScore W2913071400C142724271 @default.
- W2913071400 hasConceptScore W2913071400C160160445 @default.
- W2913071400 hasConceptScore W2913071400C168563851 @default.
- W2913071400 hasConceptScore W2913071400C181199279 @default.
- W2913071400 hasConceptScore W2913071400C185592680 @default.
- W2913071400 hasConceptScore W2913071400C204787440 @default.
- W2913071400 hasConceptScore W2913071400C27081682 @default.
- W2913071400 hasConceptScore W2913071400C2776954865 @default.
- W2913071400 hasConceptScore W2913071400C2777075537 @default.
- W2913071400 hasConceptScore W2913071400C2777180221 @default.
- W2913071400 hasConceptScore W2913071400C2778384471 @default.
- W2913071400 hasConceptScore W2913071400C2778606649 @default.
- W2913071400 hasConceptScore W2913071400C2778772119 @default.
- W2913071400 hasConceptScore W2913071400C2779134260 @default.
- W2913071400 hasConceptScore W2913071400C2779306644 @default.
- W2913071400 hasConceptScore W2913071400C2779679107 @default.
- W2913071400 hasConceptScore W2913071400C2780323712 @default.
- W2913071400 hasConceptScore W2913071400C55493867 @default.
- W2913071400 hasConceptScore W2913071400C555293320 @default.
- W2913071400 hasConceptScore W2913071400C71924100 @default.
- W2913071400 hasConceptScore W2913071400C90924648 @default.
- W2913071400 hasIssue "5" @default.
- W2913071400 hasLocation W29130714001 @default.